B

Belite Bio
D

BLTE

57.620
USD
0.79
(1.39%)
مغلق
حجم التداول
317
الربح لكل سهم
-1
العائد الربحي
-
P/E
-52
حجم السوق
1,834,630,019
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار
المقالات

العنوان: Belite Bio

القطاع: Healthcare
الصناعة: Biotechnology
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively lead to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.